These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

867 related articles for article (PubMed ID: 34481722)

  • 1. National surveillance of bacterial and fungal coinfection and secondary infection in COVID-19 patients in England: lessons from the first wave.
    Gerver SM; Guy R; Wilson K; Thelwall S; Nsonwu O; Rooney G; Brown CS; Muller-Pebody B; Hope R; Hall V
    Clin Microbiol Infect; 2021 Nov; 27(11):1658-1665. PubMed ID: 34481722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
    Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
    Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-infection in critically ill patients with COVID-19: an observational cohort study from England.
    Baskaran V; Lawrence H; Lansbury LE; Webb K; Safavi S; Zainuddin NI; Huq T; Eggleston C; Ellis J; Thakker C; Charles B; Boyd S; Williams T; Phillips C; Redmore E; Platt S; Hamilton E; Barr A; Venyo L; Wilson P; Bewick T; Daniel P; Dark P; Jeans AR; McCanny J; Edgeworth JD; Llewelyn MJ; Schmid ML; McKeever TM; Beed M; Lim WS
    J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33861190
    [No Abstract]   [Full Text] [Related]  

  • 7. Bacterial and fungal co-infections among ICU COVID-19 hospitalized patients in a Palestinian hospital: a retrospective cross-sectional study.
    Naseef HA; Mohammad U; Al-Shami N; Sahoury Y; Abukhalil AD; Dreidi M; Alsahouri I; Farraj M
    F1000Res; 2022; 11():30. PubMed ID: 35811795
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
    Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
    Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coinfections with Other Respiratory Pathogens among Patients with COVID-19.
    Sreenath K; Batra P; Vinayaraj EV; Bhatia R; SaiKiran K; Singh V; Singh S; Verma N; Singh UB; Mohan A; Bhatnagar S; Trikha A; Guleria R; Chaudhry R
    Microbiol Spectr; 2021 Sep; 9(1):e0016321. PubMed ID: 34287033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Clinical Impact of Coinfection in Patients with Coronavirus Disease 2019 in Korea.
    Jeong S; Lee N; Park Y; Kim J; Jeon K; Park MJ; Song W
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35216039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of respiratory bacterial infections on mortality in Japanese patients with COVID-19: a retrospective cohort study.
    Nakagawara K; Kamata H; Chubachi S; Namkoong H; Tanaka H; Lee H; Otake S; Fukushima T; Kusumoto T; Morita A; Azekawa S; Watase M; Asakura T; Masaki K; Ishii M; Endo A; Koike R; Ishikura H; Takata T; Matsushita Y; Harada N; Kokutou H; Yoshiyama T; Kataoka K; Mutoh Y; Miyawaki M; Ueda S; Ono H; Ono T; Shoko T; Muranaka H; Kawamura K; Mori N; Mochimaru T; Fukui M; Chihara Y; Nagasaki Y; Okamoto M; Amishima M; Odani T; Tani M; Nishi K; Shirai Y; Edahiro R; Ando A; Hashimoto N; Ogura S; Kitagawa Y; Kita T; Kagaya T; Kimura Y; Miyazawa N; Tsuchida T; Fujitani S; Murakami K; Sano H; Sato Y; Tanino Y; Otsuki R; Mashimo S; Kuramochi M; Hosoda Y; Hasegawa Y; Ueda T; Takaku Y; Ishiguro T; Fujiwara A; Kuwahara N; Kitamura H; Hagiwara E; Nakamori Y; Saito F; Kono Y; Abe S; Ishii T; Ohba T; Kusaka Y; Watanabe H; Masuda M; Watanabe H; Kimizuka Y; Kawana A; Kasamatsu Y; Hashimoto S; Okada Y; Takano T; Katayama K; Ai M; Kumanogoh A; Sato T; Tokunaga K; Imoto S; Kitagawa Y; Kimura A; Miyano S; Hasegawa N; Ogawa S; Kanai T; Fukunaga K;
    BMC Pulm Med; 2023 Apr; 23(1):146. PubMed ID: 37101265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic significance of secondary bacteremia in patients with COVID-19.
    Nakagawara K; Kamata H; Chubachi S; Namkoong H; Tanaka H; Lee H; Otake S; Fukushima T; Kusumoto T; Morita A; Azekawa S; Watase M; Asakura T; Masaki K; Ishii M; Endo A; Koike R; Ishikura H; Takata T; Matsushita Y; Harada N; Kokutou H; Yoshiyama T; Kataoka K; Mutoh Y; Miyawaki M; Ueda S; Ono H; Ono T; Shoko T; Muranaka H; Kawamura K; Mori N; Mochimaru T; Fukui M; Chihara Y; Nagasaki Y; Okamoto M; Amishima M; Odani T; Tani M; Nishi K; Shirai Y; Edahiro R; Ando A; Hashimoto N; Ogura S; Kitagawa Y; Kita T; Kagaya T; Kimura Y; Miyazawa N; Tsuchida T; Fujitani S; Murakami K; Sano H; Sato Y; Tanino Y; Otsuki R; Mashimo S; Kuramochi M; Hosoda Y; Hasegawa Y; Ueda T; Takaku Y; Ishiguro T; Fujiwara A; Kuwahara N; Kitamura H; Hagiwara E; Nakamori Y; Saito F; Kono Y; Abe S; Ishii T; Ohba T; Kusaka Y; Watanabe H; Masuda M; Watanabe H; Kimizuka Y; Kawana A; Kasamatsu Y; Hashimoto S; Okada Y; Takano T; Katayama K; Ai M; Kumanogoh A; Sato T; Tokunaga K; Imoto S; Kitagawa Y; Kimura A; Miyano S; Hasegawa N; Ogawa S; Kanai T; Fukunaga K;
    J Infect Chemother; 2023 Apr; 29(4):422-426. PubMed ID: 36682606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
    Russell CD; Fairfield CJ; Drake TM; Turtle L; Seaton RA; Wootton DG; Sigfrid L; Harrison EM; Docherty AB; de Silva TI; Egan C; Pius R; Hardwick HE; Merson L; Girvan M; Dunning J; Nguyen-Van-Tam JS; Openshaw PJM; Baillie JK; Semple MG; Ho A;
    Lancet Microbe; 2021 Aug; 2(8):e354-e365. PubMed ID: 34100002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors.
    Ripa M; Galli L; Poli A; Oltolini C; Spagnuolo V; Mastrangelo A; Muccini C; Monti G; De Luca G; Landoni G; Dagna L; Clementi M; Rovere Querini P; Ciceri F; Tresoldi M; Lazzarin A; Zangrillo A; Scarpellini P; Castagna A;
    Clin Microbiol Infect; 2021 Mar; 27(3):451-457. PubMed ID: 33223114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis.
    Musuuza JS; Watson L; Parmasad V; Putman-Buehler N; Christensen L; Safdar N
    PLoS One; 2021; 16(5):e0251170. PubMed ID: 33956882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial coinfections in COVID-19: an underestimated adversary.
    Fattorini L; Creti R; Palma C; Pantosti A; ;
    Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
    Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus disease 2019 (COVID-19) associated bacterial coinfection: Incidence, diagnosis and treatment.
    Wu HY; Chang PH; Chen KY; Lin IF; Hsih WH; Tsai WL; Chen JA; Lee SS;
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 1):985-992. PubMed ID: 36243668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial/fungal infection in hospitalized patients with COVID-19 in a tertiary hospital in the Community of Castilla y León, Spain.
    Nebreda-Mayoral T; Miguel-Gómez MA; March-Rosselló GA; Puente-Fuertes L; Cantón-Benito E; Martínez-García AM; Muñoz-Martín AB; Orduña-Domingo A
    Enferm Infecc Microbiol Clin (Engl Ed); 2022 Apr; 40(4):158-165. PubMed ID: 35216948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worldwide prevalence of microbial agents' coinfection among COVID-19 patients: A comprehensive updated systematic review and meta-analysis.
    Pakzad R; Malekifar P; Shateri Z; Zandi M; Akhavan Rezayat S; Soleymani M; Karimi MR; Ahmadi SE; Shahbahrami R; Pakzad I; Abdi F; Farahani A; Soltani S; Kesheh MM; Hosseini P
    J Clin Lab Anal; 2022 Jan; 36(1):e24151. PubMed ID: 34851526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.